AT1-AA induced hypertension during pregnancy contributes to developmental programming of hypertension in female

Nathan Campbell1, James P Lemon1, Melissa Helmich2

  • 1Department of Pharmacology & Toxicology, University of Mississippi Medical Center, Jackson, MS, United States.

PubMed

Insights

Maternal exposure to agonistic autoantibodies against the angiotensin II type 1 receptor (AT1-AA) during pregnancy may increase blood pressure in female offspring. This study found elevated blood pressure and renal endothelin-1 in adult female offspring exposed to AT1-AA.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiovascular Research
  • Immunology

Background:

  • Preeclampsia (PE) involves hypertension and organ dysfunction during pregnancy.
  • Agonistic autoantibodies against the angiotensin II type 1 receptor (AT1-AA) are linked to PE.
  • The impact of prenatal AT1-AA exposure on offspring cardiovascular health is unclear.

Purpose of the Study:

  • To investigate the hypothesis that AT1-AA exposure during pregnancy contributes to hypertension in adult offspring.
  • To determine the long-term effects of AT1-AA on offspring cardiovascular and renal function.

Main Methods:

  • Pregnant rats were infused with AT1-AA from gestational day 14.
  • Offspring were aged to 4 months, and mean arterial pressure (MAP) was measured.
  • Blood and tissue samples were collected for hormonal and molecular analysis, including progesterone, endothelin-1, and circulating AT1-AA levels.

Main Results:

  • Female offspring exposed to AT1-AA exhibited elevated MAP compared to controls.
  • Elevated progesterone and renal endothelin-1 levels were observed in female AT1-AA offspring.
  • Both male and female AT1-AA offspring showed increased circulating AT1-AA levels in adulthood.

Conclusions:

  • Prenatal AT1-AA exposure can predispose female offspring to adult-onset hypertension.
  • Persistently increased renal endothelin-1 and AT1-AA are associated with this hypertension.
  • AT1-AA may play a significant role in the increased cardiovascular risk observed in offspring of preeclamptic mothers.

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.6K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
763
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K